Navigation Links
Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
Date:5/31/2012

SAN DIEGO, May 31, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Jefferies 2012 Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, June 6th at 9:30 a.m. EDT at the Grand Hyatt New York. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's website at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Contrave cardiovascular outcomes trial which the company plans to initiate this quarter. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com

Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

WCG(858) 875-8629

(510) 703-9491


'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
8. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
9. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
10. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... MedVet, a ... critical care veterinary hospital located at 601 Showers Dr., Mountain View, CA in June ... further expand access for pet care in the Silicon Valley and broader Santa Clara ...
(Date:5/21/2020)... ... ... Murrieta Genomics has partnered with Life Science Nation (LSN) ... a special discount rate to the Digital RESI 3-Day Global Conference being held June ... bring together startups with early-stage investors and strategic channel partners. The goal was to ...
(Date:5/21/2020)... ... May 21, 2020 , ... NeoTract, a wholly owned subsidiary ... urology, today announced that Naveen Divakaruni, D.O., Advocate Medical Group in Aurora, IL, ... Dr. Divakaruni has achieved a high level of training and experience with the ...
Breaking Medicine Technology:
(Date:5/21/2020)... ... 2020 , ... Fujirebio Diagnostics, Inc., a consolidated subsidiary of ... that Cigna has added ROMA® (Risk of Ovarian Malignancy Algorithm) to its national ... improving the health, well-being, and peace of mind of the customers they serve. ...
(Date:5/21/2020)... KENNESAW, Ga. (PRWEB) , ... May 21, 2020 , ... ... Representatives District 35, has been endorsed by Planned Parenthood Southeast Advocates (PPSEA). ... candidates who support family planning and the full range of reproductive health care. PPSEA ...
(Date:5/21/2020)... ... May 21, 2020 , ... The Rise of Mental ... been a lot of complications and adjustments, needless to say, more complications. With rising ... since the great depression it can be hard to escape and find peace. Adding ...
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... JNL ... care industry announced the release of the SafeHealth screening software. This tool ... the need for additional staff or the cost of additional paperwork management. , SafeHealth ...
(Date:5/16/2020)... ... , ... On May 21, T1V will host a webinar featuring Dr. David B. Agus, one ... to CBS news, as we address COVID-19 and the impact on unified communication and collaboration. ... since March, many questions are left unanswered as we look at the future of UCC ...
Breaking Medicine News(10 mins):